Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9

NCT01388075 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01388075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01388075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2011
Completion date
Not reported
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects